Dr. Michael McCollum

Claim this profile

Virginia Oncology Associates

Studies Ovarian Cancer
Studies Ovarian Tumors
8 reported clinical trials
15 drugs studied

Area of expertise

1Ovarian Cancer
Michael McCollum has run 5 trials for Ovarian Cancer. Some of their research focus areas include:
AKT positive
BRCA1 positive
PI3K positive
2Ovarian Tumors
Michael McCollum has run 4 trials for Ovarian Tumors. Some of their research focus areas include:
AKT positive
BRCA1 positive
PI3K positive

Affiliated Hospitals

Image of trial facility.
Virginia Oncology Associates
Image of trial facility.
Virginia Oncology Associates - Hampton

Clinical Trials Michael McCollum is currently running

Image of trial facility.

Mirvetuximab + Bevacizumab

for Ovarian Cancer

GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3

More about Michael McCollum

Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Michael McCollum has experience with
  • Paclitaxel
  • Mirvetuximab Soravtansine
  • Tisotumab Vedotin
  • Topotecan
  • Vinorelbine
  • Gemcitabine
Breakdown of trials Michael McCollum has run
Ovarian Cancer
Ovarian Tumors
Fallopian Tube Cancer
Peritoneal Neoplasm
Peritoneal Tumors

Other Doctors you might be interested in

Michael A. DansoVirginia Oncology Associates
McCollum, MDVirginia Oncology Associates (USOR)
Paul Conkling, MDVirginia Oncology Associates

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael McCollum specialize in?
Michael McCollum focuses on Ovarian Cancer and Ovarian Tumors. In particular, much of their work with Ovarian Cancer has involved AKT positive patients, or patients who are BRCA1 positive.
Is Michael McCollum currently recruiting for clinical trials?
Yes, Michael McCollum is currently recruiting for 1 clinical trial in Norfolk Virginia. If you're interested in participating, you should apply.
Are there any treatments that Michael McCollum has studied deeply?
Yes, Michael McCollum has studied treatments such as Paclitaxel, Mirvetuximab Soravtansine, Tisotumab Vedotin.
What is the best way to schedule an appointment with Michael McCollum?
Apply for one of the trials that Michael McCollum is conducting.
What is the office address of Michael McCollum?
The office of Michael McCollum is located at: Virginia Oncology Associates, Norfolk, Virginia 23502 United States. This is the address for their practice at the Virginia Oncology Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top